{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:19:12Z","timestamp":1781140752646,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jemermed.2024.07.005","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T15:51:47Z","timestamp":1722700307000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Rescue Sedation after 5 mg or 10 mg of Droperidol as the Initial Treatment for Acute Agitation in the Emergency Department"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7714-8826","authenticated-orcid":false,"given":"Jon B.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quin T.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber R.","family":"LeBrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Beaupre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2024.07.005_bib0001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajem.2022.01.011","article-title":"Emergency medicine updates: droperidol","volume":"53","author":"Cisewski","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0002","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0003","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajem.2021.11.011","article-title":"Rapid tranquilization of the agitated patient in the emergency department: a systematic review and network meta-analysis","volume":"51","author":"deSouza","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.annemergmed.2018.06.001","article-title":"The characteristics and prevalence of agitation in an urban county emergency department","volume":"72","author":"Miner","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/acem.14124","article-title":"Randomized double-blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department","volume":"28","author":"Martel","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0006","first-page":"1167","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel","year":"2005","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0009","first-page":"298","article-title":"Droperidol vs. haloperidol in the initial management of acutely agitated patients","volume":"45","author":"Resnick","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0013","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00005053-197704000-00008","article-title":"Droperidol in acutely agitated patients. A double-blind placebo-controlled study","volume":"164","author":"van Leeuwen","year":"1977","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jemermed.2017.10.011","article-title":"Evidence-based review of pharmacotherapy for acute agitation. part 1: onset of efficacy","volume":"54","author":"Zun","year":"2018","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0016","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jemermed.2018.12.036","article-title":"Rescue sedation when treating acute agitation in the emergency department with intramuscular antipsychotics","volume":"56","author":"Klein","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/acem.13486","article-title":"Parenteral antipsychotic choice and its association with emergency department length of stay for acute agitation secondary to alcohol intoxication","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2016.08.008","article-title":"A Prospective observational study of patients receiving intravenous and intramuscular olanzapine in the emergency department","volume":"69","author":"Cole","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0019","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.annemergmed.2023.09.010","article-title":"Clinical policy: critical issues in the evaluation and management of adult out-of-hospital or emergency department patients presenting with severe agitation: approved by the ACEP Board of Directors, October 6, 2023","volume":"83","author":"Thiessen","year":"2024","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ajem.2021.09.029","article-title":"The use of verbal de-escalation in intoxicated emergency department patients","volume":"56","author":"Klein","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of Emergency Medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/1742-6723.13173","article-title":"Impact of acutely behavioural disturbed patients in the emergency department: a prospective observational study","volume":"31","author":"Oliver","year":"2019","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0023","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.annemergmed.2021.01.005","article-title":"A prospective study of intramuscular droperidol or olanzapine for acute agitation in the emergency department: a natural experiment owing to drug shortages","volume":"78","author":"Cole","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annemergmed.2023.08.009","article-title":"Factors associated with physical restraint in an urban emergency department","volume":"83","author":"Robinson","year":"2024","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.annemergmed.2017.07.021","article-title":"Unsuspected critical illness among emergency department patients presenting for acute alcohol intoxication","volume":"71","author":"Klein","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0026","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5811\/westjem.2017.10.35052","article-title":"Emergency department frequent users for acute alcohol intoxication","volume":"19","author":"Klein","year":"2018","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0028","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0029","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/10903127.2018.1542473","article-title":"A prospective study of the safety and effectiveness of droperidol in children for prehospital acute behavioral disturbance","volume":"23","author":"Page","year":"2019","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1742-6723.13496","article-title":"Prospective study of the safety and effectiveness of droperidol in elderly patients for pre-hospital acute behavioural disturbance","volume":"32","author":"Page","year":"2020","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0031","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/10903127.2018.1445329","article-title":"A prospective before and after study of droperidol for prehospital acute behavioral disturbance","volume":"22","author":"Page","year":"2018","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0032","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/add.13780","article-title":"Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial","volume":"112","author":"Yap","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0033","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00063110-199709000-00003","article-title":"Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone","volume":"4","author":"Richards","year":"1997","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0034","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajem.2022.02.042","article-title":"Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department","volume":"55","author":"Thiemann","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(96)00259-4","article-title":"The efficacy of intravenous droperidol in the prehospital setting","volume":"15","author":"Rosen","year":"1997","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0036","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10903120190939571","article-title":"Prehospital sedation with intramuscular droperidol: a one-year pilot","volume":"5","author":"Hick","year":"2001","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10903120590891723","article-title":"Discontinuation of droperidol for the control of acutely agitated out-of-hospital patients","volume":"9","author":"Martel","year":"2005","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0038","unstructured":"American Society of Health-System Pharmacists. ASHP Policy Positions 1982\u22122023. https:\/\/www.ashp.org\/-\/media\/assets\/policy-guidelines\/docs\/browse-by-document-type-policy-positions-1982-2023-with-rationales-pdf.pdf. Accessed January 11, 2024."},{"key":"10.1016\/j.jemermed.2024.07.005_bib0039","unstructured":"U.S. Food and Drug Administration. Guideline for industry: dose-response information to support drug registration. https:\/\/www.fda.gov\/media\/71279\/download. Accessed January 12, 2024."},{"key":"10.1016\/j.jemermed.2024.07.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620958910","article-title":"The art and science of drug titration","volume":"11","author":"Caffrey","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0041","unstructured":"Kelly G. American Regent Re-introduces Droperidol Injection, USP; AP Rated and Therapeutically Equivalent to Inapsine\u00ae 2019. https:\/\/www.americanregent.com\/media\/2276\/pp-dp-us-0011_droperidol_pressrelease_14feb2019.pdf. Accessed January 5, 2024."},{"key":"10.1016\/j.jemermed.2024.07.005_bib0042","first-page":"32","article-title":"Large-volume IM injections: a review of best practices","volume":"4","author":"Hopkins","year":"2013","journal-title":"Oncol Nurse Advisor"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0043","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/15563650.2018.1564324","article-title":"The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome","volume":"57","author":"Lee","year":"2019","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0044","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal de-escalation of the agitated patient: Consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup","volume":"13","author":"Richmond","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2015.11.028","article-title":"Ketamine as rescue treatment for difficult-to-sedate severe acute behavioral disturbance in the emergency department","volume":"67","author":"Isbister","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0052","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajem.2023.03.058","article-title":"Retrospective evaluation of ketamine versus droperidol on time to restraint removal in agitated emergency department patients","volume":"69","author":"Krenz","year":"2023","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0047","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/acem.12842","article-title":"A large retrospective cohort of patients receiving intravenous olanzapine in the emergency department","volume":"23","author":"Martel","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0048","first-page":"1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ajem.2021.12.039","article-title":"Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients","volume":"52","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0049","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jemermed.2022.12.012","article-title":"Droperidol use in the emergency department: a clinical review","volume":"64","author":"Siegel","year":"2023","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department","volume":"21","author":"Cole","year":"2020","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.07.005_bib0046","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jemermed.2023.01.010","article-title":"Emergency department management of patients with alcohol intoxication, alcohol withdrawal, and alcohol use disorder: a white paper prepared for the American Academy of Emergency Medicine","volume":"64","author":"Strayer","year":"2023","journal-title":"J Emerg Med"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467924002348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467924002348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T19:13:48Z","timestamp":1737314028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467924002348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"alternative-id":["S0736467924002348"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2024.07.005","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue Sedation after 5 mg or 10 mg of Droperidol as the Initial Treatment for Acute Agitation in the Emergency Department","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2024.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}